                               SEQUENCE LISTING

<110> ABEXXA BIOLOGICS, INC.
 
<120> COMBINATION CANCER THERAPY WITH ANTI-CANCER AGENTS AND ANTIBODIES
      TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND 
      NEOANTIGEN

<130> 50626-705.601

<140> PCT/US2019/019295
<141> 2019-02-22

<150> 62/634,522
<151> 2018-02-23

<160> 1     

<170> PatentIn version 3.5

<210> 1
<211> 9
<212> PRT
<213> Homo sapiens

<400> 1
Val Met Ala Pro Arg Thr Leu Phe Leu 
1               5                   


